INDO US BIO-TECH | TRANSCHEM | INDO US BIO-TECH/ TRANSCHEM |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 16.5 | 255.6% | View Chart |
P/BV | x | 8.6 | 0.8 | 1,024.5% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH TRANSCHEM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
TRANSCHEM Mar-23 |
INDO US BIO-TECH/ TRANSCHEM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 38 | 330.2% | |
Low | Rs | 25 | 16 | 158.7% | |
Sales per share (Unadj.) | Rs | 61.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 7.2 | 1.0 | 714.2% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 1.0 | 790.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 53.8 | 101.0% | |
Shares outstanding (eoy) | m | 10.03 | 12.24 | 81.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0 | - | |
Avg P/E ratio | x | 10.4 | 26.6 | 39.2% | |
P/CF ratio (eoy) | x | 9.4 | 26.4 | 35.4% | |
Price / Book Value ratio | x | 1.4 | 0.5 | 277.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 329 | 229.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 8 | 167.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 0 | - | |
Other income | Rs m | 0 | 42 | 0.5% | |
Total revenues | Rs m | 618 | 42 | 1,455.0% | |
Gross profit | Rs m | 94 | -17 | -542.3% | |
Depreciation | Rs m | 8 | 0 | 10,325.0% | |
Interest | Rs m | 12 | 0 | 120,100.0% | |
Profit before tax | Rs m | 74 | 25 | 295.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 13 | 11.5% | |
Profit after tax | Rs m | 72 | 12 | 585.3% | |
Gross profit margin | % | 15.2 | 0 | - | |
Effective tax rate | % | 2.0 | 50.6 | 3.9% | |
Net profit margin | % | 11.7 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 579 | 103.5% | |
Current liabilities | Rs m | 123 | 1 | 13,658.9% | |
Net working cap to sales | % | 77.1 | 0 | - | |
Current ratio | x | 4.9 | 643.4 | 0.8% | |
Inventory Days | Days | 1 | 0 | - | |
Debtors Days | Days | 146,261,410 | 0 | - | |
Net fixed assets | Rs m | 90 | 83 | 107.8% | |
Share capital | Rs m | 100 | 122 | 81.9% | |
"Free" reserves | Rs m | 445 | 536 | 83.0% | |
Net worth | Rs m | 545 | 658 | 82.8% | |
Long term debt | Rs m | 17 | 0 | - | |
Total assets | Rs m | 689 | 662 | 104.0% | |
Interest coverage | x | 7.2 | 2,505.0 | 0.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0 | - | |
Return on assets | % | 12.3 | 1.9 | 655.8% | |
Return on equity | % | 13.3 | 1.9 | 707.1% | |
Return on capital | % | 15.3 | 3.8 | 401.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 12 | 43.2% | |
From Investments | Rs m | -67 | -9 | 709.2% | |
From Financial Activity | Rs m | 63 | NA | - | |
Net Cashflow | Rs m | 1 | 3 | 50.5% |
Indian Promoters | % | 70.2 | 51.7 | 135.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 48.3 | 61.7% | |
Shareholders | 1,166 | 13,813 | 8.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | TRANSCHEM |
---|---|---|
1-Day | 8.77% | -2.28% |
1-Month | 26.17% | 62.03% |
1-Year | 113.64% | 119.85% |
3-Year CAGR | 152.58% | 26.08% |
5-Year CAGR | 42.16% | 14.08% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the TRANSCHEM share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of TRANSCHEM the stake stands at 51.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of TRANSCHEM.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
TRANSCHEM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of TRANSCHEM.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.